Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials Article Early Access

International Collaboration

cited authors

  • Li, Lee X.; Cappuzzo, Federico; Matos, Ignacio; Socinski, Mark A.; Hopkins, Ashley M.; Sorich, Michael J.

authors

Publication Date

  • March 11, 2023

webpage

published in

category

keywords

  • chemoimmunotherapy
  • hyperprogression
  • hyperprogressive disease
  • immune checkpoint inhibitor
  • non-small cell lung cancer